Seppic and Botalys (a Belgian start-up specialized in the cultivation of rare and medicinal plants) have signed a research partnership for the co-development of new ingredients for the cosmetic and health markets. The two structures have also agreed on the distribution of Botalys products on various markets.
“To meet the growing demand from the cosmetic and nutraceutical industries for performance and naturalness, Seppic and Botalys are partnering to provide high quality ingredients to cosmetic and health care manufacturers,” the two companies said.
“We are very pleased with this new partnership with Botalys. This agreement is fully in line with our corporate strategy to develop natural ingredients based on innovative technologies and to distribute high performance proprietary ingredients for the cosmetic and dietary supplement markets, while strengthening our focus on the development of new supply chains,” said Hannes Moeller, CEO of Seppic.
“This partnership with Seppic is very exciting for Botalys’ teams. Our innovative and proprietary precision farming technology addresses the need for purity, efficiency and security of supply of many rare medicinal plants. This scientific and commercial partnership outlines the huge potential of this technology for the nutraceutical and cosmetic industry”, added Pierre-Antoine Mariage, CEO of Botalys.
